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Introduction: Biomarkers in
Neurodevelopmental Toxicology
by Herbert L. Needleman*
The search for markers oftoxicant exposure and ef-
fect upon the development oforganisms presents a set
of challenges that differ in many ways from those en-
countered in the study of markers in reproduction or
pregnancy. These latter two fields specify a relatively
narrow set of organs or biological systems. The term
"development," on the other hand, can apply to any
organ system, or to any set ofphenomena that changes
in an ordered way overtime. Forthisreason the papers
presented in the session on development were chosen
to narrow the focus to neurodevelopmental markers, as
such markers may be altered by neurotoxic exposure.
In attempting to meet this somewhat daunting task,
we have been able to select agroup ofinvestigators who
work at the leading edges of their respective fields of
developmental neuroanatomy, neurotoxicology, neu-
roendocrinology, neuropsychology, and infant devel-
opment. Inintroducingthistopic, Iofferafewsummary
comments on the utility of some behavioral measures,
particularly measures of attention, as markers; on the
meaning of "adverse health effect"; on the importance
ofprior information about the sensitivity and specificity
ofanycandidatemarker; and oncertainepistemicissues
encountered in drawing causal inferences.
The notion that toxicants could affect behavior cer-
tainly is not new. Recent knowledge that behavioral
aberrations can occur at exposures below those which
produce organic changes, and that behavioral obser-
vation might provide early markers ofeffect has given
rise to two new fields: behavioral toxicology and be-
havioral teratology.
Teachers as Behavioral
Toxicologists
The application of behavioral markers in evaluating
neurotoxins does not require behavioral toxicologists;
itcanbedone, forexample, byteachers. Figure 1 shows
the responses ofall the first and second grade teachers
inSomerville and Chelsea, MA, whenasked tocomplete
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an 11-itemforcedchoicequestionnairegradingtheclass-
room performance ofover 2000 students whose dentine
lead levels were known (1). As dentine lead level in-
creases, the proportion of bad reports for each item
increases in regular monotonic fashion. The same in-
strument, in the hands of British and Greek teachers
applied to schoolchildren classified by blood lead levels,
produced strikingly similar results (2,3).
Attention as a Marker
One of the behavioral functions that appears to be
most responsive to neurotoxins is attention. A number
ofthe contributors to this symposium address this com-
petence. Figure 2 displays two experiments in which
reaction time at two intervals of delay, a measure of
vigilance, are plotted in subjects classified by lead bur-
den (4). It can be seenthatblood lead level and reaction
time at longer intervals ofdelay are closely correlated.
This nested series of curves compiled from schoolchil-
dren in two separate countries describes a dose-re-
sponse relationship.
Values in Defining Adverse Health
Effects
Discriminatingbetweenbiologicalmarkersandhealth
markers requires specifying what is meant by an ad-
verse health effect. Isanychange ofstateinandofitself
an adverse health effect? Consider for example, free
erythrocyte protoporphyrin (FEP), a heme precursor
pigment consistently elevated atlevels oflead exposure
that are not necessarily attended by brain edema, ane-
mia, or kidney failure. Is an elevated FEP evidence of
disease? Figure 3, taken from a paperby Hernberg (5),
clarifies the question with regard to lead exposure, and
canbeappliedtoanyneurotoxin. Internalleadexposure
is plotted on the abscissa, and frequency of measured
effectis plotted on the ordinate. Anumber ofmeasured
outcomesofvariedhealthconsequence arethenplotted.
At the farright is the most serious health consequence,
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FIGURE 1. Teachers' ratings ofclassroom behavior inrelation to dentine lead level. Teachers were blind to lead levels and had known students
for at least 2 months. n = 2146. From Needleman et al. (1).
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FIGURE 2. Comparison ofreaction times at varying intervals ofdelay in subjects at four different exposure levels. Two separate studies are
plotted here: Needleman et al. (1) and Hunter et al. (4). The data are ordered by mean blood lead level for each group.
will occur. Dloo represents the uniformly lethal dose.
At the far left of the graph is plotted a very sensitive
response that begins at the lowest measurable expo-
sure. One can visualize a family of curves, each repre-
senting adifferent outcome, eachhavingits ownthresh-
old and frequency distribution. For some outcomes,
using lead as a paradigm, there will be no quarrel as to
the health significance, e.g., death, brain hemorrhage,
or renal tubular disease.
For other outcomes, the definition of adverse health
effect is more ambiguous, and values play a significant
role. Figure 4 displays intensity of any given effect
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FIGURE 3. Frequency response of various outcomes in relation to internal dose oflead. From Hernberg (5).
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FIGURE 4. Intensity of any single effect in relation to lead dose.
Influence ofjudgment on definition of adverse health effect.
against the dose of the agent. It shows that some out-
comes (noncritical, nonrate-limiting) are very small de-
gress of effect that are of little health consequence to
the host, and other outcomes are of undoubted health
relevance. It is between these boundaries that the ar-
gument of health significance exists, and sometimes
rages. It can be seen that in the positioning of these
boundaries, questions of value inevitably insert them-
selves.
Sensitivity and Specificity of
Markers
The use of markers in screening enterprises for dis-
eases of low prevalence can produce surprising results
ifone is unaware ofthe prior probabilities and the sen-
sitivity and specificity of the marker. Sensitivity and
specificity are defined in Table 1.
Let us imagine a marker of quite high sensitivity
(0.9), and excellent specificity (0.95) applied to a rela-
tively rare disease, with a rate of 10/100,000. Table 2
shows that if a population of 100,000 were completely
sampled, 5000 false positive diagnoses would be made
Table 1. Definitions of sensitivity' and specificity.b
Marker Disease present Disease absent
Present a b
Absent c d
'Sensitivity = a/(a + c).
bSpecificity = d/(d + b).
Table 2. Use of a highly sensitive marker for a rare disease.'
Marker Disease present Disease absent
Present 9 5000
Absent 1 949,900
'Disease rate = 10/100,000.
Table 3. Use of a highly sensitive marker for a common
disease.a
Marker Disease present Disease absent
Present 900 4950
Absent 100 94,050
aDisease rate = 1000/100,000.
in order to find 9 true cases of the disease. Table 3
appliesthe sameanalysistoarelativelycommondisease
(rate = 1%), and shows that even with a test of this
high quality, the false positive rate is 5.5 timesthe true
positive rate. The rational use of markers to diagnose
disease requires information on specificity, sensitivity,
and the prior knowledge of the disease rate. This is a
requirement too often ignored.
Type I and Type 11 Errors in Causal
Inferences
The establishment ofcausal relationships is a central
issue in the validation of disease representation. If a
given outcome or marker is posited to be an effect of a
neurotoxin, the establishment of a causal nexus is en-
tailed in validating the status of the outcome as a
marker. This is no simple task, particularly in obser-
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vational studies with multiple predictor variables.
There are two types of errors to be made. Scientists
have longbeenjustifiably concerned with avoidingtype
I oralpha errors: acceptingspurious errors asreal. This
is felt to be defending scientific rigor; it avoids super-
stitious behavior, and limits the number of erroneous
papers in the literature and the need for replications to
invalidate spurious relationships.
Less attention has beenpaidtotype II orbetaerrors:
treatingrealrelationships as spurious. Listedbeloware
a few methodologic or epistemic solecisms frequently
encounteredwhichincreasethechanceoftype IIerrors.
Makingp = 0.05 Sacrosant
Many authors interpret studies with p values of0.06
or 0.1 as not significant and infer that no relationship
existsinnature. R. A. Fisher, creatorofthesignificance
test, treated the value p = 0.05 differently in his book
The Design ofExperiments:
It is convenient to take this point [p = 0.05] as a limit in
judging whether a deviation is to be considered significant
or not. Deviations exceeding twice the standard deviation
are thus formally regarded as significant.
It is relevant to note the use ofthe term "convenient."
There is nothing sacred about this value. Jerome Corn-
feld's comments on this point are worth noting:
[T]he prespecification of a significance level, e.g., .05 or
.01 has no sound logical basis and remains unjustified.
The Building of Nonveridical Models
(Overcontrol)
Variates that are measured in a study may be inde-
pendent variables which affect the outcome under ex-
amination, orthey may themselves be affected by lead.
They may in fact occupy both positions in the causal
chain. To control for such variates may be to subtract
out variance which properly belongs to the main effect.
Investigators are required at the least to report the
results with and without controlling for these variates.
Making No-Effect Inferences from
Samples of Inadequate Power
Many studies have reported finding no effect when
the sample size chosen has inadequate power to find an
effect ifit were present.
Demanding Causal Proof
Two hundred years ago, David Hume stated that
causality is a concept not susceptible to empirical dem-
onstration. Epidemiologists, and bench scientists as
well, accept more modest goals for themselves: the ac-
cretion ofincremental bits ofdata that assemble them-
selves into a coherent picture from which lawfulness
can be inferred. They should not be burdened with a
philosophically unreachable goal.
Inthe section to follow, the authors examine the neu-
robiologic and behavioral substrates that will provide
the material from which to extract valid and efficacious
markers oftoxicity. Joseph Altman examines the effect
of precisely timed doses of X-irradiation upon micro-
neuronal migration and consequent behaviors. He has
shown that precise measures of cellular migration can
be correlated with altered behaviors that resemble at-
tention deficit. Barry Hoffer discusses the model he has
developed for studying neurogenesis and those factors
which impede it. Bruce McEwen's studies ofthe effects
of hormones and pseudohormones on brain anatomy
have enriched our understanding ofgender differences
in structure and behavior, and imply that many behav-
iors may be markers for early CNS-hormone interac-
tions. Edward Tronick's studies of early infant com-
petence are among those which have sharpened our
abilities to discover risk factors earlier in the course of
achild's life andtofollowthedevelopmental elaboration
of such risks. Alan Mirsky discusses his model of at-
tentional function, drawn from his long and intensive
studies in primate and seizure states in humans.
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